ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 559

$449K Total Retail Price of All Prescriptions

Rank: 45 out of 559

440 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 440 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 440 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 510 478 1 2
LISINOPRIL 380 349 2 1
SIMVASTATIN 321 289 3 3
OMEPRAZOLE 236 228 4 4
AMLODIPINE BESYLATE 204 182 5 6
METFORMIN HCL 181 161 6 5
METOPROLOL TARTRATE 170 166 7 12
HYDROCODONE-ACETAMINOPHEN 152 141 S3 8 7
LOVASTATIN 150 135 9 10
FUROSEMIDE 148 142 10 11
CRESTOR 124 111 11 33
CITALOPRAM HBR 121 121 12 21
LOSARTAN POTASSIUM 120 116 13 14
TAMSULOSIN HCL 120 109 13 25
ADVAIR DISKUS 108 89 15 46
GABAPENTIN 102 86 16 9
FLUTICASONE PROPIONATE 99 83 17 22
HYDROCHLOROTHIAZIDE 96 87 18 8
ALENDRONATE SODIUM 96 96 18 13
TRAZODONE HCL 93 83 20 28
TRAMADOL HCL 90 84 21 27
PREDNISONE 86 74 22 49
RANITIDINE HCL 82 79 23 26
ZETIA 80 80 24 101
METOPROLOL SUCCINATE 77 70 25 16
FINASTERIDE 71 71 26 59
ATENOLOL 71 70 26 15
AZITHROMYCIN 69 64 28 39
DONEPEZIL HCL 67 67 29 36
NAMENDA 66 66 30 56
MELOXICAM 65 63 31 42
ZOLPIDEM TARTRATE 62 60 32 17
ALLOPURINOL 58 58 33 34
POTASSIUM CHLORIDE 57 57 34 23
PROAIR HFA 56 50 35 29
PANTOPRAZOLE SODIUM 55 51 36 41
ESCITALOPRAM OXALATE 53 49 37 109
ONGLYZA 52 48 38 200
CLOPIDOGREL 52 47 38 51
PLAVIX 51 49 40 76
METFORMIN HCL ER 51 51 40 75
DOXAZOSIN MESYLATE 50 50 42 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.